No effects on morphological development were observed in embryo-fetal enhancement studies with oral administration of methylphenidate to pregnant rats and rabbits in the course of organogenesis at doses as much as 10 and fifteen times, respectively, the maximum suggested human dose (MRHD) of 60 mg/working day supplied to adolescents over a mg/m2 fo